Mountain in the Pennine Alps on the border between Switzerland and Italy
POPULARITY
Categories
140 episodes with Matterhorn
19 episodes with Matterhorn
13 episodes with Matterhorn
29 episodes with Matterhorn
22 episodes with Matterhorn
7 episodes with Matterhorn
6 episodes with Matterhorn
5 episodes with Matterhorn
6 episodes with Matterhorn
2 episodes with Matterhorn
4 episodes with Matterhorn
4 episodes with Matterhorn
3 episodes with Matterhorn
5 episodes with Matterhorn
5 episodes with Matterhorn
8 episodes with Matterhorn
5 episodes with Matterhorn
5 episodes with Matterhorn
This week on Sent from Disneyland, we set sail through Frontierland with two vintage postcards and a fascinating look at a forgotten piece of Disney history. Our first postcard, mailed in 1971, features the Mark Twain Riverboat steaming along the Rivers of America with the Matterhorn rising in the distance. A simple note to a friend captures a memorable day spent at Disneyland with family, while the postcard itself serves as a gateway into the history of the Tru-Vue Company. Long before View-Master became a household name, Tru-Vue was producing stereoscopic film viewers that brought destinations and stories to life in three dimensions. In this episode, we explore the evolution of stereoscopes, Disney's licensing agreement with Tru-Vue, and the Frontierland film cards produced during Disneyland's earliest years. A second postcard takes us back to 1959 and the Disneyland Railroad, featuring the C.K. Holliday pausing at the original Frontierland station and water tower. That image connects directly to the Frontierland Tru-Vue card in the collection, allowing us to examine all seven scenes preserved on the film strip—from the Frontierland entrance and stagecoaches to pack mules, the Mark Twain, and rare views of attractions that no longer exist in their original form. The episode concludes with an incoming postcard from Oregon's beloved Enchanted Forest theme park, sparking a discussion about regional storybook parks, childhood memories, and the unique charm of attractions inspired by classic fairy tales rather than major intellectual properties. Below are some of the regulars on Art Throw Down, Follow all of them on Instagram anyway for great art and postcards in your Instagram feed: Hipstadufus, luluvision, jlynch9923, greenmosspaper, georgemailsart, state_of_the_funyun, RussRomano2021
Am 14. Juli 1865 stehen 7 Männer am Gipfel des Matterhorns. Edward Whymper, der als Erstbesteiger in die Geschichte eingehen wird, hält in seinen Notizen fest: „Um 13.40 Uhr lag die Welt zu unseren Füßen – das Matterhorn war bezwungen. Hurra!“ Aber nur wenige Stunden später sind vier seiner Kameraden tot. Die Erstbesteigung des Matterhorns war ein Wettlauf um Ruhm zwischen zwei Ländern und zwischen zwei Männern, die einst gemeinsam losgezogen waren, den unbezwingbaren Berg zu erobern. Es war ein Sieg des Bergsteigens und gleichzeitig das Ende der goldenen Ära des Alpinismus. In dieser Bergwelten Backstage Folge spricht Host Mara Simperler mit dem stellvertretenden Bergwelten-Chefredakteur Klaus Haselböck über die Erstbesteigung des Matterhorns 1865 und welche Lehren wir auch 160 Jahre später noch aus dem Unglück ziehen können.
Drop us a message with any questions you may have :)The White Out Podcast – Live from Everest Base Camp with Kenton CoolDom Killinger and Rob Stewart speak live to British mountaineer and mountain guide Kenton Cool from Everest Base Camp, just days before he attempts his 20th summit of the world's highest mountain.Broadcast directly from Nepal at an altitude of more than 5,300 metres, the interview offers a unique insight into life on Everest, the realities of high-altitude guiding and the challenges of leading clients in some of the world's most extreme environments.Kenton discusses his journey from growing up in Buckinghamshire to becoming one of Britain's most accomplished mountaineers, his long-standing relationship with Nepal and the Sherpa community, and why he continues to return to Everest year after year.The episode covers:• Preparing for a 20th ascent of Everest• Life at Everest Base Camp and how expeditions operate• The physical and mental challenges of climbing at extreme altitude• How mountain guides make difficult decisions under pressure• The relationship between guides, Sherpas and clients• Learning to ski as an adult in Chamonix• Ski touring, mountaineering and skiing 8,000-metre peaks• The similarities between guiding in the Alps and the Himalayas• The rewards and responsibilities of being a mountain guide• Why saying "no" is sometimes the most important decision a guide can makeThe panel also discuss:• Climate change and its impact on glaciers in the Alps and Himalayas• The future of skiing in a warming climate• Avalanche risk and decision-making in the mountains• The next generation of climbers, skiers and mountaineers• Skiing in Pakistan and other remote mountain regions• Kenton's favourite ski destinations around the world• The enduring appeal of the Arlberg ski regionHighlights include:• Kenton speaking live from Everest Base Camp just before leaving for his summit push• His reflections on nearly two decades of Everest expeditions• Honest discussion about client pressure and mountain safety• Insights into the effects of climate change on mountain environments• Stories from Chamonix, Pakistan, Nepal and some of the world's biggest peaks• Kenton's answer to The White Out's regular "one ski resort for life" questionSelected quotes from the show:"Summits are kind of irrelevant. The number is irrelevant. It's the environment that I get to be in and working in.""It is work. I'm an Everest guide. This is one of the ways I pay the mortgage.""If it's good for climbing, it's crap for skiing. If it's good for skiing, it's crap for climbing.""There is pressure on the mountain guide, whether it's here, whether it's the Matterhorn or skiing the Vallée Blanche.""We are employed as guides for a reason. To be the decision maker.""We think we've underestimated it. By the end of this century there won't be a single glacier left in Europe.""If you're passionate about it, just do it."Check out: www.kentoncool.comSupport the showIn the meantime Enjoy the mountains :) And Please do leave a review as it's the only way other like minded travellers get to find us! And don't forget to check us out on the following channels inthesnow.cominstagram.com/inthesnowTikTok@inthesnowmag youtube.com/inthesnowmagfacebook.com/inthesnowTo contact us with your suggestions for further episodes at dom@InTheSnow.com / robert@ski-press.com
'At 6,812 metres high, when I waved my white flag, I spontaneously cried, ‘Punjabi aa gye oye' (Punjabis have arrived),” says Sukhvir Kaur, also known as Sukhi Bal, a Punjabi woman who has summited Mount Ama Dablam. Known as the ‘Matterhorn of the Himalayas' for its pyramid-like peak and steep ridges, Ama Dablam is considered one of the world's most challenging climbs. Like the mountain she conquered, Sukhi too is tough and versatile. Originally from Chehal village in Punjab's Patiala district, she now works as a prison officer in Sydney and previously appeared in Punjabi films. To hear more about her remarkable journey and adventures, listen to the full podcast. - 'ਜਦੋਂ ਮੈਂ 6,812 ਮੀਟਰ ਉੱਚੀ ਨੇਪਾਲ ਦੀ ਖਤਰਨਾਕ ਅਤੇ ਚੁਣੌਤੀਪੂਰਨ ਚੋਟੀ ਮਾਊਂਟ ਐਮਾ ਦਬਲਮ ਉੱਤੇ ਪਹੁੰਚ ਕੇ ਸਫੇਦ ਚੁੰਨੀ ਹਵਾ ਵਿੱਚ ਲਹਿਰਾਈ, ਤਾਂ ਮੇਰੇ ਮੂੰਹੋਂ ਆਪ-ਮੁਹਾਰੇ ਨਿੱਕਲਿਆ – ਪੰਜਾਬੀ ਆ ਗਏ ਓਏ!' ਇਹ ਜਜ਼ਬਾਤੀ ਸ਼ਬਦ ਹਨ ਆਸਟ੍ਰੇਲੀਆ ਵੱਸਦੀ ਪੰਜਾਬਣ ਸੁਖਵੀਰ ਕੌਰ ਉਰਫ਼ ਸੁੱਖੀ ਬੱਲ ਦੇ, ਜਿਨ੍ਹਾਂ ਨੇ ਦੁਨੀਆ ਦੀ ਸਭ ਤੋਂ ਉੱਚੀ ਚੋਟੀ ਮਾਊਂਟ ਐਵਰੈਸਟ ਦੇ ਨੇੜੇ ਸਥਿਤ ਮਾਊਂਟ ਐਮਾ ਦਬਲਮ ਨੂੰ ਫਤਿਹ ਕਰ ਕੇ ਇੱਕ ਮਿਸਾਲ ਪੈਦਾ ਕੀਤੀ ਹੈ।
On this episode of Metal on Metal, we sat down with Sean Arsenian of the Montreal based sludge metal band The Great Sabatini. In this interview, we discuss their classic album Matterhorn. We also discuss 4am studio sessions. eating shit on the road, community, and unearthing family history. This episode is brought to you by Third Moon Brewery. Use code "metalonmetal" to get free beer shipping to most places in Ontario from Third Moon Brewery at thirdmoonbrewing.com. Links mentioned in this episode: *https://thegreatsabatini.bandcamp.com/album/matterhorn This podcast is hosted by ZenCast.fm
2:09 - Indiana Jones background 7:26 - Indy ride run through 11:00 - Who is the attraction for/not for 13:14 - Line strategies 15:51 - Indiana Jones tier ranking 17:53 - Matterhorn basics 20:22 - Attraction run through 24:45 - Who the attraction is for/not for 27:02 - Line strategies 29:26 - Matterhorn tier rankings
Heiko Thieme Club - Von LVMH bis Deutsche Bank: Kaufen, schwitzen, absichern. Matterhorn-Märkte: Wenn Euphorie steil wird hier geht es direkt zur heutigen Ausgabe: https://www.heiko-thieme.club/2026/05/12/heiko-thieme-club-von-lvmh-bis-deutsche-bank-kaufen-schwitzen-absichern-matterhorn-maerkte-wenn-euphorie-steil-wird/ Die Märkte bewegen sich zwischen KI-Euphorie, Ölschock und geopolitischer Unsicherheit. Seine Diagnose: ein heißer Sommer an den Börsen, mit Chancen, aber auch mit spürbarem Risiko. Bei LVMH sieht er den Luxuswert nach rund 30 % Kursrückgang "kurz vor dem Kauf" und erklärt daran seine Drei-Tranchen-Strategie. Beim Verkauf bleibt er pragmatisch: Wer 25 % Gewinn hat, darf ein Drittel realisieren oder mit Stopps absichern. Bei ETFs gilt Ähnliches: Manuelas Batterie-ETF ist mit +70 % stark gelaufen, ein Stopp bei etwa +60 % wäre für ihn plausibel. BioNTech streicht Thieme dagegen weitgehend vom Zettel, Moderna bleibt für ihn interessanter. Im DAX-Check von BMW bis Deutsche Bank fällt sein Urteil differenziert aus: BMW neutral, Brenntag nach der Rally kein Neukauf, Commerzbank haltenswert, Continental nur mit Stopp, Daimler Truck möglich, aber kein Top-Favorit. Klar positiv wird er bei der Deutschen Bank: Nach dem Rücksetzer ist sie wieder kaufbar, idealerweise in Tranchen. Außerdem: Schaeffler reizt Heiko wenig, Meta ist ihm aktuell zu teuer, Google findet er spannender.
This week, as we enter our 200th episode, Michael and Josh continue their journey through the alimentary canal, exploring the world of stomach cancer. Gastric cancer has been notoriously difficult to treat, with a thirty-year grace period of multiple trials seeking an appropriate regimen that reduces recurrences while remaining effective. This episode gives you all the answers, and just when we thought everything was settled, immunotherapy enters the fray with MATTERHORN.Studies discussed in this episode:FLOT4-AIOMATTERHORN For more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.
Callista Gingrich ist seit letztem Herbst neue Botschafterin der USA in der Schweiz und in Lichtenstein. Bisher fällt sie vor allem mit Instagram-Posts der schönsten Orte der Schweiz auf: vom Matterhorn in Zermatt, dem Rhein in Basel, einer Schaukäserei im Emmental. Politisch spürt man in Bern wenig von ihr. Stattdessen stellt sich ihr Ehemann in den Vordergrund: Newt Gingrich ist innerhalb der Maga-Bewegung eine wichtige Figur. Wer ist der wahre Botschafter, die wahre Botschafterin in Bern? Wie nahe steht das Ehepaar Gingrich US-Präsident Donald Trump? Und wie wichtig ist der Kontakt zum Botschaftspaar für die Schweizer Politik? In einer neuen Folge des täglichen Podcasts «Apropos» spricht Bundeshausredaktor Fabian Fellmann über die Dynamiken rund um die US-Botschafterin in Bern. Host: Philipp Loser Produktion: Sibylle Hartmann Artikel zu US-Botschafterin Callista Gingrich: US-Botschafterin in Bern: Wer vertritt Trump in der Schweiz wirklich – Newt oder Callista Gingrich? Trump-Vertraute Callista Gingrich: US-Botschafterin zum Zolldeal: «Wir wollen, dass die Schweiz zum fünftgrössten Investor wird» Seilziehen in den USA: Trumps Botschafterin für die Schweiz steht kurz vor der Einsetzung – nach neun Monaten Wartezeit Unser Tagi-Spezialangebot für Podcast-Hörer:innen: tagiabo.chHabt ihr Feedback, Ideen oder Kritik zu «Apropos»? Schreibt uns an podcasts@tamedia.ch Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
This week, Sent from Disneyland continues its mailbox tour with two more lost Disneyland mailboxes—and one modern postcard surprise. First, a 1976 Matterhorn postcard takes us to a forgotten Tomorrowland mailbox once located beneath the Skyway, Monorail, and PeopleMover. Then, a 1965 Frontierland postcard leads us to the mailbox hidden beside the Westward Ho Trading Company and its iconic wooden Indian photo spot. Finally, an incoming 2026 postcard featuring vintage stamps and a Sinatra quote ties today's mail magic back to Disneyland. Along the way: park history, extinct attractions, vintage stamps, and the stories written on the backs of postcards. Below are some of the regulars on Art Throw Down, Follow all of them on Instagram anyway for great art and postcards in your Instagram feed: Hipstadufus, luluvision, jlynch9923, greenmosspaper, georgemailsart, state_of_the_funyun, RussRomano2021
One Hit Wonders met Daantjie Dinamiet - Matterhorn Project se 'Moo!'
CONTACT US TODAY! PATREON: http://www.patreon.com/wttmpodcast TikTok: https://www.tiktok.com/@windowtothemagic YouTube: http://youtube.com/windowtothemagic Email: podcast@windowtothemagic.com Voicemail: 1-307-GET-WTTM (438-9886) On this episode, Part 3 of 3, Paul takes on Fantasyland at Disneyland. Join Paul as he continues exploring Fantasyland and then does every Fantasyland attraction (except Matterhorn) in near real time. This is classic WTTM podcast fun, when we go in and literally share the in-park experience with you. Very little editing here... just binaural audio of the heart of Walt's original Magic Kingdom. Enjoy!! 52 mins ))HD BINAURAL((
Before there was Disneyland, Bob Gurr was part of Walt Disney's secret team. One of the original Disney Imagineers, Gurr designed Matterhorn, Autopia, Monorail, Haunted Mansion and anything on wheels at Disneyland. A true Disney legend, he is also an L.A. Native and regales us with stories of how L.A. has changed over his 90+ years - and what he likes best about Disneyland, even if he didn't design it!
Hey, Scuttlebutt listeners. Thank you for joining us and for your continued support. This week, we bring another installment of our new series, Literary Lethality, to the scuttlebutt. In this series, we will be doing a deep dive into the Commandant's Professional Reading List, exploring various titles and talking to different authors about some of the books on the list. Today, Michael Jerome Plunkett was kind enough come on and talk to us about Karl Marlantes' novel, Matterhorn. Matterhorn is on the CPRL as part of the Leadership category, and Michael, as the creator of the PBA Abbate Book Club and host of the LitWar podcast, discusses the aspects of this novel that speak to leadership and decision making, some good and some bad, in life-or-death situations. We also discuss the origins of the novel, which actually started as a memoir written in the 70s, who the intended audience is, what Marlantes is trying to communicate with the book, and some of the takeaways for today's service members. And more than anything, why Matterhorn deserves to be on the Commandant's Professional Reading List. Enjoy! mca-marines.org/commandants-professional-reading-list-leadership/?pg=2 michaeljeromeplunkett.com Matterhorn: A Novel of the Vietnam War The post #234: Literary Lethality – Matterhorn with Michael Jerome Plunkett first appeared on Marine Corps Association.
Hey, Scuttlebutt listeners. Thank you for joining us and for your continued support. This week, we bring another installment of our new series, Literary Lethality, to the scuttlebutt. In this series, we will be doing a deep dive into the Commandant's Professional Reading List, exploring various titles and talking to different authors about some of the books on the list. Today, Michael Jerome Plunkett was kind enough come on and talk to us about Karl Marlantes' novel, Matterhorn. Matterhorn is on the CPRL as part of the Leadership category, and Michael, as the creator of the PBA Abbate Book Club and host of the LitWar podcast, discusses the aspects of this novel that speak to leadership and decision making, some good and some bad, in life-or-death situations. We also discuss the origins of the novel, which actually started as a memoir written in the 70s, who the intended audience is, what Marlantes is trying to communicate with the book, and some of the takeaways for today's service members. And more than anything, why Matterhorn deserves to be on the Commandant's Professional Reading List. Enjoy! mca-marines.org/commandants-professional-reading-list-leadership/?pg=2 michaeljeromeplunkett.com Matterhorn: A Novel of the Vietnam War The post #234: Literary Lethality – Matterhorn with Michael Jerome Plunkett first appeared on Marine Corps Association.
Eric and Lauren unpack a wild week in the Disney parks, from the growing debate around live streamers and park etiquette to Disney's latest efforts to win back middle-class families. They also dive deep into the Disneyland vs. Walt Disney World snack showdown and share a costly lesson about choosing between Lightning Lane and Park Hopper. It's a mix of park culture, planning strategy, and plenty of food opinions. HIGHLIGHTS A live streamer incident at Disneyland sparks a bigger conversation about safety, swatting risks, and whether live streaming should be restricted in the parks The difference between respectful content creators and disruptive live streamers, including real guest and cast member frustrations Disney's new push to attract middle-class families with lower ticket options, discounts, and kid-focused experiences Expanded low-tier ticket availability, summer promotions, and added value offerings across Disneyland and Walt Disney World The ongoing value debate: breaking down cost-per-hour and whether Disney is still “worth it” compared to other entertainment Disneyland vs. Walt Disney World snacks: why Lauren says Disneyland wins and Eric… just eats everything Standout Disneyland snacks including the raspberry macaron, Matterhorn cream puff, and cheesy garlic pretzel bread A Disneyland strategy mistake: skipping Lightning Lane leads to a $600 Park Hopper decision mid-day Food & Wine Festival crowds at Disney California Adventure and how timing can completely change your park experience The big planning question: Park Hopper or Lightning Lane at Disneyland - and why the answer isn't so simple HOSTS Eric Hersey – X: @erichersey | Instagram: @erichersey Lauren Hersey – X: @laurenhersey2 | Instagram: @lauren_hersey_ FOLLOW – DIS & HERS Website: DisAndHers.com Instagram: @disandhers TikTok: @disandhers Facebook: Dis and Hers YouTube: Dis & Hers FOLLOW – JIM HILL MEDIA Facebook: JimHillMediaNews Instagram: JimHillMedia TikTok: JimHillMedia SUPPORT Support the show and access bonus episodes and additional content at Patreon.com/JimHillMedia. PRODUCTION CREDITS Edited & Produced by Eric Hersey – Strong Minded Agency If you would like to sponsor a show on the Jim Hill Media Podcast Network, reach out today. Learn more about your ad choices. Visit megaphone.fm/adchoices
Are you dreaming of seeing the Matterhorn up close, riding one of Switzerland's most iconic mountain railways, or discovering breathtaking views without the crowds? Then this episode is for you!Join me as I chat with Gabi Aberle, Head of Overseas Markets at Matterhorn Gotthard Railway, for an insider's guide to the classic Zermatt to Gornergrat cogwheel train journey. We answer everything you need to know about the famous Gornergrat train, including tips for getting the best Matterhorn views and why Gornergrat deserves a place on every Switzerland itinerary.We discuss why the Gornergrat railway station is the gateway to incredible alpine adventures - whether you're hiking to the famous Riffelsee for that perfect reflective Matterhorn photo, admiring the Gorner Glacier, or visiting the Gornergrat Observatory. Plus, Gabi tells us about the Gornergrat Golden Spot, the ideal spot for an Instagram-worthy photo, and you'll hear about the immersive ZOOOM the Matterhorn experience.Not sure when to plan your excursion? We discuss the best time to go up Gornergrat, and share practical advice for maximizing your visit. Find out how your Swiss Travel Pass saves you money on this mountain highlight, and whether or not you should buy your Gornergrat tickets in advance. Tune in for essential details including how to get to Gornergrat from Zermatt, must-know tips for hopping off along the route, where to eat with unbeatable views, and how to make your Gornergrat trip truly unforgettable. Whether you're staying overnight at the Gornergrat hotel or just visiting for the day, we cover it all to ensure your visit to Zermatt and Gornergrat will be the highlight of your Swiss travels.Happy travels,Carolyn
Ryan Vesce, a former NHL player and CEO of Matterhorn Fit a pain management and rehabilitation facility joins Enterprise Fit Radio. Recently, Matterhorn turned … Read more The post Changing Pain Management: A New Franchise Solution appeared first on Top Entrepreneurs Podcast | Enterprise Podcast Network.
Brian Yandle and Mike Mottau are back with an interview with Ryan Vesce, a long time professional hockey player and co-founder and CEO of Matterhorn Fit! Before Ryan joins, the guys recap their week around the rink, talk about some trades that happened prior to the deadline on Friday, and hit on the local high school playoffs that are underway in Massachusetts. Then the boys welcome in Ryan to talk about his career and more including: Playing hockey undersized BY versus Ryan in the Frozen Four Kids needing more awareness when it comes to physicality Developing Matterhorn Fit and watching it grow BY & Motts wrap up the show by answering the My Hockey Rankings question of the week and Motts gives his Motts moment lock of the week. Thank you for listening! Please rate, review, and subscribe! If you're interested in sponsoring the show, please reach out to us by email or DM us on Instagram! Leave us a voicemail: 347-6-SHRINK Email: RinkShrinks@gmail.com Instagram: @TheRinkShrinks Twitter: @RinkShrinks Join the community! https://community.thehockeythinktank.com/signup?am_id=rinkshrinks Youtube: www.YouTube.com/Bleav Today's Episode Was Sponsored By: TSR Hockey My Hockey Rankings Franklin Sports Neutral Zone FanDuel Revive DNA- Revive | Sleep, Performance & Health Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
CONTACT US TODAY! PATREON: http://www.patreon.com/wttmpodcast TikTok: https://www.tiktok.com/@windowtothemagic YouTube: http://youtube.com/windowtothemagic Email: podcast@windowtothemagic.com Voicemail: 1-307-GET-WTTM (438-9886) On this episode, Part 2 of 3, Paul takes on Fantasyland at Disneyland. Join Paul as he continues exploring Fantasyland and then does every Fantasyland attraction (except Matterhorn) in near real time. This is classic WTTM podcast fun, when we go in and literally share the in-park experience with you. Very little editing here... just binaural audio of the heart of Walt's original Magic Kingdom. Enjoy!! 62 mins ))HD BINAURAL((
In this episode, Janina travels to Switzerland's Valais – a dramatic Alpine region that is home to one of the highest concentrations of indigenous grape varieties in the world. She is joined by José Vouillamoz, leading authority on grape origins and DNA profiling, co-author of Wine Grapes, and author of Swiss Grapes, to explore Valais' ancient varieties, genetic mysteries, heroic viticulture and why this small region quietly produces some of the world's best Syrah. From Petit Arvine and Amigne to Cornalin, Humagne Rouge and age-worthy Chasselas (Fendant), this is a fascinating deep dive into Swiss wine history, science and flavour. 02:59 The coolest fact about Valais - the world's smallest vineyard owned by the Dalai Lama. 05:21 Janina links back to her episode (Ep 75) on the most unique vineyards in the world. 05:59 Why Valais is genetically unique - indigenous grapes found nowhere else. 07:22 Is Valais the most concentrated region for native grape varieties? 10:01 The Alpine landscape - terraces, dry stone walls and heroic viticulture. 12:22 Where to begin with indigenous grapes - Petit Arvine explained. 14:02 Angelo Gaja's failed attempt to plant Arvine in Piemonte. 15:47 Arvine vs Petit Arvine – understanding the naming confusion. 16:51 How producers label Arvine today - Petit Arvine or simply Arvine? 17:20 The rare Gross Arvine - what it is and why it almost disappeared. 19:14 What does Gross Arvine taste like? 19:58 Amigne - Valais' misunderstood chameleon grape. 21:15 The bee-label system that indicates sweetness levels in Amigne wines. 22:24 Heida (Savagnin/Païen/Traminer) - is it indigenous to Valais? 24:07 Can you identify Valais Heida in a blind tasting? 26:21 Other white grapes worth seeking out - Humagne Blanc and Rèze. 28:57 Chasselas (Fendant) - why it plays such an important role in Valais. 31:19 The ageing mystery - how low-acid Chasselas can evolve for decades. 33:10 Humagne Blanc vs Humagne Rouge - is there a genetic connection? 36:04 Cornalin (Rouge du Pays) - why this red is worth discovering. 38:28 Humagne Rouge - flavour profile and distinctive character. 39:35 Syrah in Valais - why this may be its northern quality limit. 45:26 If you try only one grape from Valais - which should it be? 46:15 Must-visit spots - Zermatt, the Matterhorn, Aletsch Glacier and Visperterminen vineyards. 49:26 The food to try - authentic Swiss raclette and ideal wine pairings. 51:23 José's book Swiss Grapes and the upcoming updated edition. To discover more about the Valais wine region go to https://swisswinevalais.ch/en/ Follow José Vouillamoz on Instagram for more insights into Swiss wine, grape genetics and fascinating discoveries from the world of viticulture.
Risk Isn't Reckless | Elite Risk Management with SuperFrenchie What does it take to make decisions when the margin for error is zero? In this episode of The Heartbeat for Hire Podcast, Lyndsay sits down with Matthias Giraud — better known as SuperFrenchie — two-time world record–holding ski BASE jumper, professional alpinist, and the only person in history to ski BASE jump the Alps Trilogy: Eiger, Matterhorn, and Mont Blanc. Known for GoPro's first viral avalanche cliff jump and featured on 60 Minutes, CNN Headline News, and international media worldwide, Matthias has amassed over 100+ million cumulative views across social, YouTube, and global television. But this conversation isn't about adrenaline. It's about discipline. It's about fear. It's about clarity under pressure. This episode explores the psychology behind extreme performance, dismantles the myth of the "adrenaline junkie," and reframes risk as a leadership competency — not a personality trait. Episode Summary In this episode of The Heartbeat for Hire Podcast, Lynz welcomes two-time world record-holding ski BASE jumper Matthias Giraud, famously known as "SuperFrenchie." Matthias shares his journey from the French Alps to becoming a professional mountain athlete and the only person to ski BASE jump the "Alps Trilogy" — the Eiger, Matterhorn, and Mont Blanc. The conversation dives deep into the psychology of extreme sports, debunking the myth of the adrenaline addict and instead focusing on elite risk management, the necessity of fear, and finding fulfillment through self-calibration. In This Episode, You'll Learn: 1️⃣ How elite performers evaluate risk before emotion takes over 2️⃣ Why fear is not the enemy — but a required data point 3️⃣ How preparation, humility, and presence create sustainable performance Key Takeaways Fulfillment Over Adrenaline The Power of Self-Calibration Failure as a Teacher Honor Your Inner Child Personal Accountability Episode Chapters [00:00] – The Illusion of Arrogance [03:15] – Redefining the "Adrenaline Junkie" [06:04] – The Origin of "Super Frenchy" [08:50] – Honoring the Inner Child [12:15] – Self-Calibration vs. Failure [14:45] – The "Weather Report" Philosophy [17:30] – Managing Fear and Anxiety [20:10] – The Alps Trilogy [23:55] – Vulnerability in Leadership [27:20] – The Concept of "Active Waiting" [30:45] – Defining Success [33:15] – Final Thoughts and Where to Follow About Matthias Giraud Matthias Giraud (SuperFrenchie) is a professional mountain athlete specializing in alpinism, steep skiing, and BASE jumping. He is a two-time world record holder for highest ski BASE jump and has completed numerous first descents and ski BASE jumps worldwide, including: First ski BASE jump off Eiger First ski BASE jump off Matterhorn First ski BASE jump off Mont Blanc First ski BASE jump off Mt. Hood First Night Ski BASE Jump He has performed and spoken for global organizations including Apple, Facebook, and NetApp and continues to produce high-engagement content across social and YouTube. Follow Matthias: Instagram: @superfrenchieofficial
Are you planning your Swiss itinerary and wondering “Is Zermatt worth visiting?” This episode will answer that question - with a resounding ‘yes'. I'm joined by local expert, Viviane Zellweger, for a winter walk in Zermatt to get a local's perspective on the best things to do in Zermatt.Viviane answers the questions most first-time visitors ask, from “Where is Zermatt in Switzerland?” to the best ways to experience its world-famous mountains, how to get to Zermatt and what to do there.Viviane shares insider tips on unique activities like walking the picturesque Pensioners' Trail (perfect if you're looking for free things to do in Zermatt), visiting the historic Hinterdorf area in Zermatt village, and exploring the fascinating Matterhorn Museum (Zermatlantis). You'll also get the lowdown on Zermatt hiking trails and learn how to enjoy the magic of the Zermatt mountains no matter your fitness level.Not a skier? No problem winter activities in Zermatt for non-skiers, including scenic walks, snowshoeing, cross-country skiing, and even spa indulgence. Viviane also shares her tips for where to eat in Zermatt, recommending delicious Swiss classics at mountain restaurants. Join us for a virtual winter hike in Zermatt, gaze at the Matterhorn, and get inspired for your Swiss adventure. Don't miss the practical tips that will make planning your Zermatt trip easier than ever, no matter what time of year you plan to visit!You can watch the video of this episode on YouTube.Happy travels,Carolyn
In this episode, I'm taking you to Switzerland and to the Valais Canton. I recently returned from a trip to three very different ski resorts: Les Marécottes, Verbier, and Bettmeralp. Each was beautiful in its own way, but it was the Aletsch Arena that truly stayed with me. It has been described as an insider's secret resort or a hidden gem. But it is well known to the Swiss and it's where they go to ski.In this episode, I'm joined by local expert David Kestens, who helps bring the Aletsch Arena to life. We talk about the car-free mountain villages of Riederalp, Bettmeralp, and Fiescheralp. David gives us an insiders guide to the insiders secret resort. I found myself deeply drawn to the Aletsch Arena, not just for its scenery, but for the feeling it creates. We also explore what the region offers throughout the year, from peaceful alpine walks in summer to skiing and snowshoeing in the winter months.The Aletsch Arena is home to the Great Aletsch Glacier, the longest glacier in the Alps, and forms part of one of Switzerland's most remarkable UNESCO World Heritage Sites. Surrounded by more than forty peaks rising over four thousand metres including the Matterhorn, Mont Blanc, and the Eiger. It's a place that naturally encourages you to slow down and take a breath.We also chat about Les Marécottes, and about what is possibly Switzerland's most famous ski resort, Verbier. A place that's very personal to me. I've visited Verbier many times over the years and it's where I first learned to ski.Join me as we explore why the Aletsch Arena, and the wider Valais region, are among the most special places to visit, from the stunning mountain villages to the wonderful train, and discover why they may just earn a place on your Switzerland bucket list.If you haven't already, I'd ask you to give me a follow on whichever platform you listen to your podcasts and you will be the first to get a new episode.Stays Marecottes - https://www.zoo-alpin.ch/fr/zoo-boutique-hotelButtmeralps - https://www.sporting-bettmeralp.ch Fergal O'Keeffe is the host of Ireland's No.1 Travel Podcast Travel Tales with Fergal which is now listened to in 140 countries worldwide. The podcast aims to sharesoul-lifting travel memoirs about daydream worthy destinations. Please follow me onInstagram @traveltaleswithfergalFacebook @traveltaleswithfergalTwitter @FergalTravelYouTube @traveltaleswithfergal Hosted on Acast. See acast.com/privacy for more information.
Dr. Pedro Barata and Dr. Ugwuji Maduekwe discuss the evolving treatment landscape in gastroesophageal junction and gastric cancers, including the emergence of organ preservation as a selective therapeutic goal, as well as strategies to mitigate disparities in care. Dr. Maduekwe is the senior author of the article, "Organ Preservation for Gastroesophageal Junction and Gastric Cancers: Ready for Primetime?" in the 2026 ASCO Educational Book. TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast series from ASCO that features compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also the deputy editor of the ASCO Educational Book. Gastric and gastroesophageal cancers are the fifth most common cancer worldwide and the fourth leading cause of cancer-related mortality. Over the last decade, the treatment landscape has evolved tremendously, and today, organ preservation is emerging as an attainable but still selective therapeutic goal. Today, I'm delighted to be speaking with Dr. Ugwuji Maduekwe, an associate professor of surgery and the director of regional therapies in the Division of Surgical Oncology at the Medical College of Wisconsin. Dr. Maduekwe is also the last author of a fantastic paper in the 2026 ASCO Educational Book titled "Organ Preservation for Gastroesophageal Junction and Gastric Cancers: Ready for Prime Time?" We explore these questions in our conversations today. Our full disclosures are available in the transcript of this episode as well. Welcome. Thank you for joining us today. Dr. Ugwuji Maduekwe: Thank you, Dr. Barata. I'm really, really glad to be here. Dr. Pedro Barata: There's been a lot of progress in the treatment of gastric and gastroesophageal cancers. But before we actually dive into some of the key take-home points from your paper, can you just walk us through how systemic therapy has emerged and actually allowed you to start thinking about a curative framework and really informing surgery decision-making? Dr. Ugwuji Maduekwe: Great, thank you. I'm really excited to be here and I love this topic because, I'm terrified to think of how long ago it was, but I remember in medical school, one of my formative experiences and why I got so interested in oncology was when the very first trials about imatinib were coming through, right? Looking at the effect, I remember so vividly having a lecture as a first-year or second-year medical student, and the professor saying, "This data about this particular kind of cancer is no longer accurate. They don't need bone marrow transplants anymore, they can just take a pill." And that just sounded insane. And we don't have that yet for GI malignancies. But part of what is the promise of precision oncology has always been to me that framework. That framework we have for people with CML who don't have a bone marrow transplant, they take a pill. For people with GIST. And so when we talk about gastric cancers and gastroesophageal cancers, I think the short answer is that systemic therapy has forced surgeons to rethink what "necessary" really means, right? We have the old age saying, "a chance to cut is a chance to cure." And when I started out, the conversation was simple. We diagnose the cancer, we take it out. Surgery's the default. But what's changed really over the last decade and really over the last five years is that systemic therapy has gotten good enough to do what is probably real curative work before we ever enter the operating room. So now when you see a patient whose tumor has essentially melted away on restaging, the question has to shift, right? It's no longer just, "Can I take this out?" It's "Has the biology already done the heavy lifting? Have we already given them systemic therapy, and can we prove it safely so that maybe we don't have to do what is a relatively morbid procedure?" And that shift is what has opened the door to organ preservation. Surgery doesn't disappear, but it becomes more discretionary. Necessary for the patients who need it, and within systems that can allow us to make sure that we're giving it to the right patients. Dr. Pedro Barata: Right, no, that makes total sense. And going back to the outcomes that you get with these systemic therapies, I mean, big efforts to find effective regimens or cocktails of therapies that allow us to go to what we call "complete response," right? Pathologic complete response, or clinical complete response, or even molecular complete response. We're having these conversations across different tumors, hematologic malignancies as well as solid tumors, right? I certainly have those conversations in the GU arena as well. So, when we think of pathologic CRs for GI malignancies, right? If I were to summarize the data, and please correct me if I'm wrong, because I'm not an expert in this area, the traditional perioperative chemo gives you pCRs, pathologic complete response, in the single digits. But then when you start getting smarter at identifying biologically distinct tumors such as microsatellite instability, for instance, now you start talking about pCRs over 50%. In other words, half of the patients' cancer goes away, it melts down by offering, in this case, immunotherapy as a backbone of that neoadjuvant. But first of all, this shift, right, from going from these traditional, "not smart" chemotherapy approaches to kind of biologically-driven approaches, and how important is pCR in the context of "Do I really need surgery afterwards?" Dr. Ugwuji Maduekwe: That's really the crux of the entire conversation, right? We can't proceed and we wouldn't be able to have the conversation about whether organ preservation is even plausible if we hadn't been seeing these rates of pathologic complete response. If there's no viable tumor left at resection, did surgery add something? Are we sure? The challenge before this was how frequently that happened. And then the next one is, as you've already raised, "Can we figure that out without operating?" In the traditional perioperative chemo era, pathologic complete response was relatively rare, like maybe one in twenty patients. When we go to more modern regimens like FLOT, it got closer to one in six. When you add immunotherapy in recent trials like MATTERHORN, it's nearly triple that rate. And it's worth noting here, I'm a health services-health disparities researcher, so we'll just pause here and note that those all sound great, but these landmark trials have significant representation gaps that limit and should inform how confidently we generalize these findings. But back to what you just said, right, the real inflection point is MSI-high disease where, with neoadjuvant dual-checkpoint blockade, trials like NEONIPIGAS and INFINITY show pCR rates that are approaching 50% to 60%. That's not incremental progress, that's a whole new different biological reality. What does that mean? If we're saying that 50% to 60% of the people we take to the OR at the time of surgery will end up having no viable tumor, man, did we need to do a really big surgery? But the problem right now is the gold standard, I think we would mostly agree, the gold standard is pathologic complete response, and we only know that after surgery. I currently tell my patients, right, because I don't want them to be like, "Wait, we did this whole thing." I'm like, "We're going to do this surgery, and my hope is that we're going to do the surgery and there will be no cancer left in your stomach after we take out your stomach." And they're like, "But we took out my stomach and you're saying it's a good thing that there's no cancer." And yes, right now that is true because it's a measure of the efficacy of their systemic therapy. It's a measure of the biology of the disease. But should we be acting on this non-operatively? To do that, we have to find a surrogate. And the surrogate that we have to figure out is complete clinical response. And that's where we have issues with the stomach. In esophageal cancer, the preSANO protocol, which we'll talk about a little bit, validated a structured clinical response evaluation. People got really high-quality endoscopies with bite-on biopsies. They got endoscopic ultrasounds. They got fine-needle aspirations and PET-CT, and adding all of those things together, the miss rate for substantial residual disease was about 10% to 15%. That's a number we can work with. In the stomach, it's a lot more difficult anatomically just given the shape of people's stomachs. There's fibrosis, there's ulceration. A fair number of stomach and GEJ cancers have diffuse histology which makes it difficult to localize and they also have submucosal spread. Those all conceal residual disease. I had a recent case where I scoped the patient during the case, and this person had had a 4 cm ulcer prior to surgery, and I scoped and there was nothing visible. And I was elated. And on the final pathology they had a 7 cm tumor still in place. It was just all submucosal. That's the problem. I'm not a gastroenterologist, but I would have said this was a great clinical response, but because it's gastric, there was a fair amount of submucosal disease that was still there. And our imaging loses accuracy after treatment. So the gap between what looks clean clinically and what's actually there pathologically remains very wide. So I think that's why we're trying to figure it out and make it cleaner. And outside of biomarker-selected settings like MSI-high disease, in general, I'm going to skip to the end and our upshot for the paper, which is that organ preservation, I would say for gastric cancer particularly, should remain investigational. I think we're at the point where the biology is increasingly favorable, but our means of measurement is not there yet. Dr. Pedro Barata: Gotcha. So, this is a perfect segue because you did mention the SANO, just to spell it out, "Surgery As Needed for Oesophageal" trial, so SANO, perfect, I love the abbreviation. It's really catchy. It's fantastic, it's actually a well-put-together perspective effort or program applying to patients. And can you tell us how was that put together and how does that work out for patients? Dr. Ugwuji Maduekwe: Yeah, I think for those of us in the GI space, we have SANO and then we also have the OPRA for rectum. SANO for the upper GI is what takes organ preservation from theory to something that's clinically credible. The trial asked a very simple question. If a patient with a GEJ adenocarcinoma or esophageal adenocarcinoma achieved what was felt to be a clinical complete response after chemoradiation, would they actually benefit from immediate surgery? And the question was, "Can you safely observe?" And the answer was 'yes'. You could safely observe, but only if you do it right. And what does that mean? At two years, survival with active surveillance was not inferior to those who received an immediate esophagectomy. And those patients had a better early quality of life. Makes sense, right? Your quality of life with an esophagectomy versus not is going to be different. That matters a lot when you consider what the long-term metabolic and functional consequences of an esophagectomy are. The weight loss, nutritional deficiencies that can persist for years. But SANO worked because it was very, very disciplined and not permissive. You mentioned rigor. They were very elegant in their approach and there was a fair amount of rigor. So there were two main principles. The first was that surveillance was front-loaded and intentional. So they had endoscopies with biopsies and imaging every three to four months in the first year and then they progressively spaced it out with explicit criteria for what constituted failure. And then salvage surgery was pre-planned. So, the return-to-surgery pathway was already rehearsed ahead of time. If disease reappeared, take the patient to the OR within weeks. Not sit, figure out what that means, think about it a little bit and debate next steps. They were very clear about what the plan was going to be. So they've given us this blueprint for, like, watching people safely. I think what's remarkable is that if you don't do that, if you don't have that infrastructure, then organ preservation isn't really careful. It's really hopeful. And that's what I really liked about the SANO trial, aside from, I agree, the name is pretty cool. Dr. Pedro Barata: Yeah, no, that's a fantastic point. And that description is spot on. I am thinking as we go through this, where can this be adopted, right? Because, not surprisingly, patients are telling you they're doing a lot better, right, when you don't get the esophagus out or the stomach out. I mean, that makes total sense. So the question is, you know, how do you see those issues related to the logistics, right? Getting the multi-disciplinary team, getting the different assessments of CR. I guess PETs, a lot of people are getting access to imaging these days. How close do you think this is, this kind of program, to be implemented? And maybe I would assume it might need to be validated in different settings, right, including the community. How close or how far do you think you see that being applied out there versus continuing to be a niche program, watch and wait program, in dedicated academic centers? Dr. Ugwuji Maduekwe: I love this question. So I said at the top of this, I'm a health equity/health disparities researcher, and this is where I worry the most. I love the science of this. I'm really excited about the science. I'm very optimistic. I don't think this is a question of "if," I think it's a question of "when." We are going to get to a point where these conversations will be very, very reasonable and will be options. One of the things I worry about is: who is it going to be an option for? Organ preservation is not just a treatment choice, and I think what you're pointing out very rightly is it's a systems-level intervention. Look at what we just said for SANO. Someone needs to be able to do advanced endoscopy, get the patients back. We have to have the time and space to come back every three to four months. We have to do molecular testing. There needs to be multi-disciplinary review. There needs to be intensive surveillance, and you need to have rapid access to salvage surgery. Where is that infrastructure? In this country, it's mostly in academic centers. I think about the panel we had at ASCO GI, which was fantastic. And as we were having the conversation, you know, we set it up as a debate. So folks were debating either pro-surveillance or pro-surgery. But both groups, both people, were presenting outcomes based on their centers. And it was folks who were fantastic. Dr. Molena, for example, from Memorial Sloan Kettering was talking about their outcomes in esophagectomies [during our session at GI26], but they do hundreds of these cases there per year. What's the reality in this country? 70% to 80% to 90%, depending on which data you look at, of the gastrectomies in the United States occur at low-volume hospitals. Most of the patients at those hospitals are disproportionately uninsured or on government insurance, have lower income and from racial and ethnic minority groups. So if we diffuse organ preservations without the system to support it, we're going to create a two-tiered system of care where whether you have the ability to preserve your organs, to preserve bodily integrity, depends on where you live and where you're treated. The other piece of this is the biomarker testing gap. One of the things that, as you pointed out at the beginning, that's really exciting is for MSI-high tumors. Those are the patients that are most likely to benefit from immunotherapy-based organ preservation. But here's the problem. If the patient isn't tested at time of initial diagnosis before they ever see me as a surgeon, the door to organ preservation is closed before it's ever open. And testing access remains very inconsistent across academic networks. And then there's the financial toxicity piece where, for gastrectomy, pancreatectomy, I do peritoneal malignancies, more than half of those patients experience significant financial toxicity related to their cancer treatment. We're now proposing adding at least two years, that's the preliminary information, right? It's probably going to be longer. At least a couple of years of surveillance visits, repeated endoscopies, immunotherapy costs. How are we going to support patients through that? We're going to have to think about setting up navigation support, geographic solutions, what financial counseling looks like. My patient for clinic yesterday was driving to see me, and they were talking about how they were sliding because it was snowing. And they were sliding for the entire three-hour drive down here. Are we going to tell people like that that they need to drive down to, right, I work at a high-volume center, they're going to need to come here every three months, come rain or snow, to get scoped as opposed to the one-time having a surgery and not needing to have the scopes as frequently? My concern, like I said, I'm an optimist, I think it is going to work. I think we're going to figure out how to make it work. I'm worried about whether when we deploy it, we widen the already existing disparities. Dr. Pedro Barata: Gotcha, and that's a fantastic summary. And as I'm thinking also of what we've been talking in other solid tumors, which one of the following do you think is going to evolve first? So we are starting to use more MRD-based assays, which are based on blood test, whether it's a tumor-informed ctDNA or non-informed. We are also trying to get around or trying to get more information response to systemic therapies out of RNA-seq through gene expression signatures, or development of novel therapeutics which also can help you there. Which one of these areas you think you're going to help this SANO-like approach move forward, or you actually think it's actually all of the above, which makes it even more complicated perhaps? Dr. Ugwuji Maduekwe: I think it's going to be all of the above for a couple of reasons. I would say if I had to pick just one right now, I think ctDNA is probably the most promising and potentially the missing piece that can help us close the gap between clinical and pathologic response. If you achieve clinical complete response and your ctDNA is negative, so you have clinical and molecular evidence of clearance, maybe that's a low-risk patient for surveillance. If you have clinical complete response but your ctDNA remains positive, I would say you have occult molecular disease and we probably need intensified therapy, closer monitoring, not observation. I think the INFINITY trial is already incorporating ctDNA into its algorithm, so we'll know. I don't think we're at the point where it alone can drive surgical decisions. I think it's going to be a good complement to clinical response evaluation, not a replacement. The issue of where I think it's probably going to be multi-dimensional is the evidence base: who are we testing? Like, what is the diversity, what is the ancestral diversity of these databases that we're using for all of these tests? How do we know that ctDNA levels and RNA-seq expression arrays are the same across different ancestral groups, across different disease types? So I think it's probably going to be an amalgam and we're going to have to figure out some sort of algorithm to help us define it based on the patient characteristics. Like, I think it's probably different, some of this stuff is going to be a little bit different depending on where in the stomach the cancer is. And it's going to be a little bit more difficult to figure out if you have a complete clinical response in the antrum and closer to the pylorus, for example. That might be a little bit more difficult. So maybe the threshold for defining what a clinical complete response needs to be is higher because the therapeutic approach there is not quite as onerous as for something at the GE-junction. Dr. Pedro Barata: Wonderful. And I'm sure AI, whether it's digitization of the pathology from the biopsies and putting all this together, probably might play a role as well in the future. Dr. Maduekwe, it's been fantastic. Thank you so much for sharing your insights with us and also congrats again for the really well-done review published. For our listeners, thank you for staying with us. Thank you for your time. We will post a link to this fantastic article we discussed today in the transcript of this episode. And of course, please join us again next month on the By the Book Podcast for more insights on key advances and innovations that are shaping modern oncology. Thank you, everyone. Dr. Ugwuji Maduekwe: Thank you. Thank you for having me. Watch the ASCO GI26 session: Organ Preservation for Gastroesophageal and Gastric Cancers: Ready for Primetime? Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Pedro Barata @PBarataMD Dr. Ugwuji Maduekwe @umaduekwemd Follow ASCO on social media: @ASCO on X (formerly Twitter) ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck Dr. Ugwuji Maduekwe: Leadership: Medica Health Research Funding: Cigna
CONTACT US TODAY! PATREON: http://www.patreon.com/wttmpodcast TikTok: https://www.tiktok.com/@windowtothemagic YouTube: http://youtube.com/windowtothemagic Email: podcast@windowtothemagic.com Voicemail: 1-307-GET-WTTM (438-9886) On this episode, Part 1 of 3, Paul takes on Fantasyland at Disneyland. Join Paul as he walks up Main Street USA, enters Fantasyland and then does every Fantasyland attraction (except Matterhorn) in near real time. This is classic WTTM podcast fun, when we go in and literally share the in-park experience with you. Very little editing here... just binaural audio of the heart of Walt's original Magic Kingdom. Enjoy!! 98 mins ))HD BINAURAL((
Bonita Norris became the youngest woman to reach both the summit of Mt Everest at just 22 and the North Pole at 23, and her story is nothing short of extraordinary. In this episode, she shares the journey that took her from school trips in North Wales to climbing some of the world's highest peaks, navigating extreme environments, and pushing the limits of what's possible. Bonita reflects on the early steps that built her career in mountaineering—starting with beginner climbing courses, funding her expeditions, and preparing for the Himalayan peaks. She opens up about the mental and physical challenges of summiting Everest, managing fear in remote and hostile environments, and how these experiences shaped her life and perspective. Now a mother of two, Bonita also discusses how she balances adventure with family life, inspiring her children to embrace courage and curiosity. From attempting K2 to climbing the Matterhorn after an eight-year hiatus, she emphasises the importance of showing up, trusting the process, and meeting opportunity with determination. Whether you're chasing literal mountains or metaphorical ones in your own life, Bonita's insights, lessons in bravery, and personal stories will motivate you to take the next bold step. *** New episodes of the Tough Girl Podcast drop every Tuesday at 7 AM (UK time)! Make sure to subscribe so you never miss the inspiring journeys and incredible stories of tough women pushing boundaries. Do you want to support the Tough Girl Mission to increase the amount of female role models in the media in the world of adventure and physical challenges? Support via Patreon! Join me in making a difference by signing up here: www.patreon.com/toughgirlpodcast. Your support makes a difference. Thank you x *** Show notes Who is Bonita The youngest person to have reached both the summit of Mt Everest (age 22) and the North Pole (age 23) Book: The Girl Who Climbed Everest (2022) Mother of 2 children Growing up and her early years Going on a school trip to North Wales and loving every moment of hiking in the mountains Finishing her A'levels and going off to South America to climb to Machu Picchu at 18 Not realising she could make a career out of mountaineering Alison Hargreaves's dying on K2 in 1995 Mothers and taking risks Being in her 2nd year at university and going to a mountaineering talk at the Royal Geographical Society Realising that she wanted to climb and wanting to climb Mt Everest I don't know how, but I'm going to make it happen Being inspired and maintaining the inspiration/motivation Why it felt so meaningful 2 years - 24 months to gain the skills, knowledge and funding Starting with a beginners climbing course Working backwards from her goal Completing the smaller milestones and trusting in the process Funding and paying for everything Heading off on her first Himalayan Expedition - Manaslu (eighth-highest mountain in the world at 8,163 metres (26,781 ft)) Getting a job, using her student loan and receiving a grant from her university Having 6 months to find £50k to join her team going to Everest. Getting out of bed bad making another call Speaking with Capital FM on the radio How everything turned around Getting the money, getting the sponsorship Why you don't need to be an Olympic Athlete to climb Everest Why you need to work on the actual problem - don't work around the problem Fitness before heading of to Nepal Doing multi-days of training without rest If you want to get good at climbing mountains, climb mountains Reflecting back on the experience Worrying about what may go wrong on the mountain Reaching the summit and how it's changed her life Understanding the risks at 22 Thoughts on letting her children climb Everest Climbing Everest with her daughter in the future Attempting to climb K2 and managing fear in remote, hostile environments Encouraging bravery and courage in her children Climbing the Matterhorn in 2025 after 8 years off climbing Not knowing if she would still enjoy it Taking the time to figure out what is next How you can connect with Bonita Final words of advice Put yourself out there and luck will meet you half way You have to show up Social Media Website: www.bonita-norris.com Linkedin: Bonita Norris
Beatrice Egli isst zuerst die Waffeln – dann spricht sie über Tourpläne, das Matterhorn, Kritik, die an ihr abprallt und ihren Po formt, Durchhalten trotz letzter Plätze und warum sie Energie am liebsten offline auftankt. Sie reagiert gewohnt charmant auf die Frage, wie es mit Florian Silbereisen läuft. Dazu: Reisen mit XXL-Koffern, geniale Pack-Hacks, Aftershowpartys ohne sie, flüstern als Erotikfaktor und ganz viel Herz, Haltung und Humor. Viel Spaß mit der neuen Folge von "Mit den Waffeln einer Frau".
This week on the podcast, Zach Kazan is joined by Kat Shoulders and Liam O'Donnell to peel back the curtain on watch press trips. Zach just got back from Colorado with Oris, so the topic is front of mind. We reached out to members of our Worn & Wound+ Slack channel to solicit questions on press trips, how they work, and how they influence (or don't influence) our coverage of brands and their watches. Let us know if you have any additional questions about press trips – this is a fun topic to discuss and this proved to be a great discussion. Hit us up in the comments with your thoughts.To stay on top of all new episodes, you can subscribe to The Worn & Wound Podcast on all major platforms including Apple Podcasts, Stitcher, Spotify, and more. You can also find our RSS feed here.And if you like what you hear, then don't forget to leave us a review.If there's a question you want us to answer you can hit us up at info@wornandwound.com, and we'll put your question in the queue. Show Notes Oris Introduces the New Big Crown Pointer Date “Bullseye”Out of Office: Exploring the Canadian Rockies with Citizen's Team PromasterJean-Claude Biver, the Matterhorn, and Carbon Fiber with Some Color: A Few Days in Zermatt with Norqain and the New Wild One
We're back, baby! Michael and Josh predicted their ESMO journey would have eons to run, and they weren't wrong! For our first episode back in 2026, we revisit the important coverage of ESMO 2025, highlighting advances in upper gastrointestinal tract and hepatobiliary cancers. This episode covers FGFR inhibitors (Bemartizumab), updates on the MATTERHORN trial, the use of immunotherapy with trastuzumab and FLOT in HER2-positive localised oesophageal carcinoma, and investigates the use of TKIs and the novel drug nofazinlimab for those with unresectable or metastatic hepatocellular carcinoma.A jam-packed episode that aims to over-deliver on information, laughter, and hope.2026 is going to be a big one!Studies:FORTITUDE-101MATTERHORNPHERFLOT/IKF-053NCT04669496For more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. MSD provided virtual participation with ESMO. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.
We're kicking off 2026 with practice-changing data fresh from GI ASCO 2026. In this episode, we were joined once again by Dr. Rachna Shroff from the University of Arizona Cancer Center to break down the four most pivotal studies in upper GI and colorectal cancers presented at the GI ASCO 2026. We dived into the latest updates that will directly impact your clinical decisions, from new standards in perioperative therapy to revolutionary front-line regimens for metastatic disease. Key topics covered in this episode: ● MATTERHORN update: Surgical outcomes & FLOT modifications with Durvalumab in resectable gastric/GEJ cancer ● HERIZON-GEA-01: Zanidatamab + chemo + Tislelizumab the new frontline standard for HER2+ gastric cancer ● BREAKWATER: Confirming Encorafenib + Cetuximab + chemo (FOLFOX or FOLFIRI) for BRAF V600E mCRC ● COMMIT: Chemo + Atezolizumab vs. Atezolizumab alone in MSI-H/dMMR metastatic colorectal cancer Tune in for this dense, insightful recap and stay ahead of the curve. Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to subscribe for more expert analysis on treatment algorithms and major conference highlights! #OncologyBrothers #GI26 #GastricCancer #ColorectalCancer #HER2 #BRAF #MSI #OncologyPodcast
Gary and Shannon kick off Hour 1 in full NFL playoff mode, admitting the emotional void left by the absence of Monday Night Football and bracing for the long offseason ahead. They react to a wild NBA moment as Steve Kerr gets ejected with Snoop Dogg on the call, then shift to breaking news with the sudden death of Rep. Doug LaMalfa, reflecting on legacy versus partisan noise. The conversation moves through foreign policy, including why Mexico is not Venezuela and eyebrow-raising talk about Greenland and NATO — before turning lighter as Gary’s dog Peter becomes an NFL playoff picker for social media. The hour wraps with the latest chapter in Lenny Dykstra’s saga and listener talkbacks about line-cutting disasters at Disneyland, culminating in a debate over the Matterhorn ride and the unforgettable discovery of the “abdominal bears.”See omnystudio.com/listener for privacy information.
What a weird day at work. Johnny in fact is not too busy to pick his own lottery numbers. So heisty.See omnystudio.com/listener for privacy information.
Carrie and Molly welcome you to listen to this replay from their Wallowa series, which does indeed require a visit to the emergency department. Join in and hear how it all goes down! The day begins with big mileage and cruisey trails, but things take a turn when climbing the Matterhorn. The sisters learn how to deal with mental fatigue and assess together when it is better to go on and when it is appropriate to stop. A member of the trio also suffers a medical issue leaving the group to give first aid and work through the issue together. In between there are also some fun stories and laughter!
Send us a textBreaking news rarely hits mountain running like this. The World Skyrunner Series is officially returning to the United States, and the Beast of Big Creek on Washington's Olympic Peninsula is the stage. We dive straight into what makes this 23K course so compelling: sustained grades exceeding 20 percent, a clean up-and-down profile that rewards efficient climbers and fearless descenders, and a summit near 6,000 feet that avoids altitude headaches without losing the punch. With 1.5x points on offer, we make the case for why European stars could cross the Atlantic and why sub-two hours might be in play.We unpack the “why here” question through logistics and strategy. Seattle's international access makes travel simple, while the terrain delivers classic skyrunning character without sprawling altitude or complex permitting. Then we zoom out: how ISF certification interacts with the World Series, the signals from Whiteface and Broken Arrow, and whether a U.S. skyrunning series is waiting in the wings. We compare philosophies too, contrasting Golden Trail's media-friendly flower loops with skyrunning's traditional aesthetic lines and discussing why a tighter global calendar could sharpen competition and improve storytelling.This is also a conversation about athlete pathways. If more U.S. events gain certification, short-trail standouts, collegiate converts, and VK specialists can build toward European icons like Matterhorn and Trofeo Kima without crossing oceans for every test. We talk rumors, real implications for the Northeast and Pacific Northwest scenes, and how brands and athletes might respond if skyrunning gains momentum here. Hit play to catch our hot takes, practical race analysis, and the questions that will define the next phase of American mountain running. If you enjoy the show, follow, share with a trail friend, and leave a quick review—what race should be the next U.S. skyrunning stop?Follow James on IG - @jameslauriello Follow the Steep Stuff Podcast on IG - @steepstuff_pod Use code steepstuffpod for 25% off your cart at UltimateDirection.com!
The happiest place on earth has some seriously fascinating holiday history! In this episode, Jake covers some standout moments from past Christmas celebrations at Disneyland. Learn about the origins of the Candlelight Processional and the jaw-dropping Christmas decoration that once adorned the Matterhorn!Listen along and join the Dis-cussion on social media @neverlandnavco
James and Katie went to the OG theme park - the Happiest Place on Earth, Disneyland!Well, they did it like three months ago at this point but now we finally have time to talk about it!Don't forget to like, subscribe, rate, review, comment, share, and ride the damn Matterhorn.SUBSCRIBE TO OUR PATREON:https://www.patreon.com/cticketpodCHECK US OUT ON YOUTUBE:https://youtube.com/@cticketpod?si=ig6ODv0zvbaXuFPhFOLLOW US ON SOCIAL MEDIA:TIKTOK: https://www.tiktok.com/@cticketpodINSTAGRAM: https://www.instagram.com/cticketpod/TWITTER: https://twitter.com/CTicketPodEMAIL US:cticketpod@gmail.comMERCH AVAILABLE NOW!https://www.teepublic.com/user/the-c-ticket-podcastThe C-Ticket Podcast: It's not the best theme park podcast, but it's probably somebody's favorite!Hosted by Nick D'Ambrosia and James PerlasMusic:Delightful D Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0 Licensehttp://creativecommons.org/licenses/by/3.0/
In this episode of The Oncology Brothers, we dived into the pivotal study of MATTERHORN, which explored the addition of Durvalumab to perioperative FLOT chemotherapy for patients with resectable gastric and gastroesophageal junction adenocarcinoma. Join us as we welcome Dr. Yelena Y. Janjigian, a medical oncologist from Memorial Sloan Kettering and the lead author of the MATTERHORN study. Dr. Janjigian shared insights on the study's design, findings, and the implications for clinical practice, including: • The significance of the study in the context of recent FDA approvals and treatment advancements. • Key survival data, including a three-year overall survival rate of 68.6% with Durvalumab. • The feasibility of combining immunotherapy with chemotherapy and impact on surgical outcomes. • Management of side effects and clinical pearls for practitioners. We also discussed the potential for extrapolating this data to esophageal adenocarcinoma and the role of PD-L1 status in treatment decisions. Whether you're a seasoned oncologist or just starting in the field, this episode is packed with valuable information to help you provide the best care for your patients. Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to like, share, and subscribe for more practice-changing updates in oncology! #MATTERHORN #GastricCancer #Immunotherapy #Durvalumab #OncologyBrothers #GIOncology
Len Testa and Jim Hill continue No Negative November with a look at Zootopia's new 4D adventure, listener trip-planning wisdom, and the surprising book that inspired Disneyland's first mountain. NEWS Zootopia: Better Zoo-gether debuts at Animal Kingdom — The Tree of Life theater gets a major refresh with a new story, water gags, and a charming Benjamin Clawhauser animatronic. Holiday highlights return — Tree of Life Awakenings now plays nightly thanks to early sunsets, and the beloved Merry Menagerie puppet experience returns November 14. Storytime with Santa Deadpool — A holiday twist hits Avengers Campus, complete with meta Christmas jokes and Greek Orthodox canon accuracy. Listener questions answered — From the best Bay Lake Tower villas for New Year's Eve fireworks to whether it's time for Tables in Wonderland to return. Disney's shrinking parades — Why the Festival of Fantasy looks lighter on dancers and floats—and how Disney's still managing two parades a day at Magic Kingdom. FEATURE The Making of the Matterhorn — Jim shares the wild story of how a 1950s family film led Walt Disney to send a postcard from Switzerland that simply said: “Build this.” How Banner in the Sky and Third Man on the Mountain inspired Walt's alpine obsession. Why the Matterhorn nearly became a luge-style attraction (yes, really). The creative legacy of director Ken Annakin, whose films also led to Swiss Family Treehouse and Sleeping Beauty Castle. Full show notes available here: Show Notes HostsJim Hill — X/Twitter: @JimHillMedia | Instagram: @JimHillMedia | Website: jimhillmedia.comLen Testa — BlueSky: @lentesta.bsky.social | Instagram: @len.testa | Website: touringplans.com Support the Show Love what we do? Support The Disney Dish on Patreon for exclusive bonus shows and early access: patreon.com/jimhillmedia Follow Us Facebook: @JimHillMediaNews | YouTube: @jimhillmedia | TikTok: @jimhillmedia Produced by Edited by Dave Grey Produced by Eric Hersey — Strong Minded Agency Sponsor This episode is brought to you by Unlocked Magic, powered by DVC Rental Store. Save up to 10% on Disney park and event tickets, including Mickey's Very Merry Christmas Party and Jollywood Nights — only at unlockedmagic.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
Len Testa and Jim Hill continue No Negative November with a look at Zootopia's new 4D adventure, listener trip-planning wisdom, and the surprising book that inspired Disneyland's first mountain. NEWS Zootopia: Better Zoo-gether debuts at Animal Kingdom — The Tree of Life theater gets a major refresh with a new story, water gags, and a charming Benjamin Clawhauser animatronic. Holiday highlights return — Tree of Life Awakenings now plays nightly thanks to early sunsets, and the beloved Merry Menagerie puppet experience returns November 14. Storytime with Santa Deadpool — A holiday twist hits Avengers Campus, complete with meta Christmas jokes and Greek Orthodox canon accuracy. Listener questions answered — From the best Bay Lake Tower villas for New Year's Eve fireworks to whether it's time for Tables in Wonderland to return. Disney's shrinking parades — Why the Festival of Fantasy looks lighter on dancers and floats—and how Disney's still managing two parades a day at Magic Kingdom. FEATURE The Making of the Matterhorn — Jim shares the wild story of how a 1950s family film led Walt Disney to send a postcard from Switzerland that simply said: “Build this.” How Banner in the Sky and Third Man on the Mountain inspired Walt's alpine obsession. Why the Matterhorn nearly became a luge-style attraction (yes, really). The creative legacy of director Ken Annakin, whose films also led to Swiss Family Treehouse and Sleeping Beauty Castle. Full show notes available here: Show Notes HostsJim Hill — X/Twitter: @JimHillMedia | Instagram: @JimHillMedia | Website: jimhillmedia.comLen Testa — BlueSky: @lentesta.bsky.social | Instagram: @len.testa | Website: touringplans.com Support the Show Love what we do? Support The Disney Dish on Patreon for exclusive bonus shows and early access: patreon.com/jimhillmedia Follow Us Facebook: @JimHillMediaNews | YouTube: @jimhillmedia | TikTok: @jimhillmedia Produced by Edited by Dave Grey Produced by Eric Hersey — Strong Minded Agency Sponsor This episode is brought to you by Unlocked Magic, powered by DVC Rental Store. Save up to 10% on Disney park and event tickets, including Mickey's Very Merry Christmas Party and Jollywood Nights — only at unlockedmagic.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
The Mousedebaters talk Sounds of DisneylandThis week on Mousedebaters, we're putting our mouse ears to the test—literally. Join Luke, Brittany, and Kami as we try to identify real sounds from videos of our Disneyland trip. Is that the Matterhorn's yeti roar or just Luke's stomach before churros? Hard to say.Then we wrap up spooky season with a perfectly deranged game of “Disney Halloween Musical Casting.” From Young Frankenstein to Little Shop of Horrors, we recast your favorite creepy musicals with Disney and Muppet characters. Think Fozzie as Igor, Ursula as Audrey II, maybe Goofy as... Frankenstein's monster?! I don't know, you'll just have to listen to find out.As always, we're not your kids' Disney podcast. PG-13 chaos for grown-up ears only.
In this episode of the Oncology Brothers podcast, we dived into the key takeaways from ESMO 2025, focusing on gastrointestinal (GI) malignancies. Join us as we welcomed Dr. Rachna Shroff, a GI medical oncologist from the University of Arizona, to discuss the latest studies and their implications for clinical practice. Episode Highlighted: • ctDNA in Colorectal Cancer: DYNAMIC-III and PEGASUS studies, examining the evolving role of ctDNA as a prognostic and potential predictive tool in early-stage colon cancer. • STELLAR-303: Learn about the promising results of immunotherapy in refractory MSI-stable colorectal cancer and the associated toxicities. • MATTERHORN: Updated data on durvalumab with FLOT in the perioperative setting is changing the standard of care for upper GI malignancies. • FORTITUDE-101 Study: FGFR2b target in metastatic gastric and GE junction adenocarcinoma. Tune in for an insightful discussion that highlights the latest advancements in oncology and their potential impact on patient care. Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to check out our previous episodes for more insights on conference highlights, recent approvals, and treatment algorithms. #ESMO2025 #GIOcology #ctDNA #ColorectalCancer #Immunotherapy #OncologyBrothers #PrecisionMedicine
Please Follow us on: Instagram or Facebook ! In this episode, Kimberly and Tommaso apologize for the delay in their latest release. They then dive into a discussion about their favorite meals in Italy, looking back at 28 years of travel. Key Points: Kimberly and Tommaso offer a sincere apology for the delayed episode. They recap their previous discussion on favorite cities and regions. The main topic is their favorite meals in Italy, spanning 28 years of travel experiences. Episode Highlight: First Italian Meals in Cervinia Kimberly and Tommaso recount a ski trip from Zermatt, Switzerland, down to Cervinia, Italy. Kimberly describes their incredible hunger after the challenging ski descent. Tommaso recalls his memorable Zuppa Valdostana, a rich beef broth soup with bread and fontina cheese. Kimberly shares her delight in eating polenta with fontina cheese and red wine. They reminisce about a Raclette lunch with Matterhorn views, marking it as a beautiful outdoor dining experience. Meals in Lago di Como and Florence: Kimberly shares a story about visiting friends in Lago di Como, coinciding with their annual Brunello bottling celebration. Tommaso describes enjoying five to seven-year-old Brunello with grilled beef prepared by an international meat dealer. Kimberly celebrates her 40th birthday lunch at Alvalu in Tremezzo, featuring simple tomato pasta, cured meats, and a beautiful fruit tart. They both recall the unique grappa infused with blueberries, made by monks. Rome and Florence Culinary Experiences: Tommaso shares his first carbonara experience in Rome in 2021, describing it as a moment of pure paradise. Tommaso notes the relaxed dining pace in Italy, contrasting it with the faster pace in America. Kimberly describes a simple, attractive enoteca in Rome where they enjoyed another carbonara and a mozzarella di bufala appetizer. Tommaso discusses his anticipation and enjoyment of Bisteca Fiorentina in Florence, splitting it with a friend. Kimberly remembers the bright and loud atmosphere of the Florentine restaurant, a contrast to their preferred dining setting. Southern Italy and Pizza Delights: Kimberly highlights her favorite meals in Puglia, particularly a salad with tuna, mozzarella, and local vegetables, drizzled with Puglian olive oil and served with local bread. Tommaso praises the simplicity and quality of Puglian bread. Tommaso declares his favorite pizza was in Ischia, preferring a heartier style with onions, mushrooms, and prosciutto. Kimberly recounts a standout Napolitano pizza experience in Torino, found in a residential neighborhood across the river. Tommaso reflects on the ongoing challenge of finding the “next best something” in Italian cuisine. Coffee and Truffles in Torino: Kimberly raves about the bicherine, a coffee layered with dark chocolate, espresso, and frothy cream, at Cafe Bicherine in Torino. Tommaso praises a wide noodle pasta with shaved white truffles, enjoyed during truffle season in Torino, paired with a bottle of Barolo. Join Kimberly and Tommaso as they revisit their most cherished Italian meals, sharing anecdotes and insights from decades of culinary adventures. Kimberly and Tommaso share their most memorable meals from 28 years of Italian travels, from ski trips to Roman trattorias. This episode explores Italy's diverse culinary landscape and the joy of savoring food and culture.
We talk lost Disney lore, a new giveaway, getting wet on the Matterhorn and more!
The Matterhorn Fit All-Path Series is here including the Western, Ontario, and Quebec. Coach Eric will be leading the charge with the All-Path Ontario event with NCAA Division 1 and OHL programs set to join!Visit matterhornfitevents.com to REQUEST REGISTRATION!Wondering where we've been? Big announcement coming soon!
Im Juli 1895 steht Albert Mummery, einer der besten Bergsteiger seiner Zeit, vor der höchsten Wand der Welt. 4.500 Meter ragt die Rupal-Wand vor ihm in die Höhe. Es ist der erste ernsthafte Versuch, einen Achttausender zu besteigen. Die Expedition endet tödlich, wie viele weitere Besteigungsversuche am Nanga Parbat im Himalaya. Wir sprechen in der Folge darüber, wie der Nanga Parbat zum Schicksalsberg der Deutschen wurde und wie es Hermann Buhl 1953 erstmals auf den Gipfel schaffte. //Erwähnte Folgen - GAG360: Unglück am Matterhorn – https://gadg.fm/360 - GAG453: Pemmikan und der Pelzhandel in Nordamerika – https://gadg.fm/453 - GAG269: Monika Ertl und ein Mord im Generalkonsulat – https://gadg.fm/269 //Literatur - Ralf-Peter Märtin: Nanga Parbat. Wahrheit und Wahn des Alpinismus, 2002. - Kriemild Buhl: Mein Vater Hermann Buhl: Der Ausnahmebergsteiger, 2024. - Podcast „Messner – ein extremes Leben“: https://www.ardaudiothek.de/sendung/messner-ein-extremes-leben/urn:ard:show:32b583b0e97d83b1/ //Aus unserer Werbung Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/GeschichtenausderGeschichte // Wir sind jetzt auch bei CampfireFM! Wer direkt in Folgen kommentieren will, Zusatzmaterial und Blicke hinter die Kulissen sehen will: einfach die App installieren und unserer Community beitreten: https://www.joincampfire.fm/podcasts/22 //Wir haben auch ein Buch geschrieben: Wer es erwerben will, es ist überall im Handel, aber auch direkt über den Verlag zu erwerben: https://www.piper.de/buecher/geschichten-aus-der-geschichte-isbn-978-3-492-06363-0 Wer Becher, T-Shirts oder Hoodies erwerben will: Die gibt's unter https://geschichte.shop Wer unsere Folgen lieber ohne Werbung anhören will, kann das über eine kleine Unterstützung auf Steady oder ein Abo des GeschichteFM-Plus Kanals auf Apple Podcasts tun. Wir freuen uns, wenn ihr den Podcast bei Apple Podcasts oder wo auch immer dies möglich ist rezensiert oder bewertet. Wir freuen uns auch immer, wenn ihr euren Freundinnen und Freunden, Kolleginnen und Kollegen oder sogar Nachbarinnen und Nachbarn von uns erzählt! Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio
Jen and Frank chat with Troy and Mimi from Disney Assembled Podcast about their recent trip to Disneyland. On this episode…
Send us a textGet ready to ROCK with Sam, Kevin, and Amanda as we honor the legacy of Fred Joerger—the rockwork artist and model builder who helped shape the very foundation of Disneyland. From miniature models of Sleeping Beauty Castle to the towering peaks of the Matterhorn and Big Thunder Mountain, Fred's work turned blueprints and concept art into believable masterpieces. We explore his career before, during, and after his time as an Imagineer, and how his fingerprints continue to tell stories at the parks today. Then, in our Imagineering Armchair segment, we dream up new ways to bring naturalistic detail and miniature magic back into the parks—just as Fred would have done. We invite you to become Armchair Imagineers with us! Please share your thoughts and join the conversation about this episode and more on our Discord!Don't miss her stories, laughs, and the Disney magic that keeps us all coming back for more!Join us in our completely free Discord https://discord.gg/4nAvKTgcRnCheck out all of our amazing sponsors!Getaway Todayhttps://www.getawaytoday.com/?referrerid=8636If you want to book a Disney Vacation, please use our friends at Getaway Today. Also, if you call 855-GET-AWAY and mention Walt's Apartment, you will get a special dose of magic Where In The Park The Podcast-“Discover the history behind the details of Disney parks and more on the Where In The Park podcast”https://whereinthepark.comCheck Out Sunken City Designs - from the mind of Louis Medinahttps://sunkencitydesigns.bigcartel.comWe are proud to be part of the Disney Podcast Family , checkout all the other great shows below https://linktr.ee/DisneyPodcastFamily
The Matterhorn, Nestlé Chocolate, and a long-standing history of neutrality, Switzerland has it all. However, the Swiss were too busy enjoying all those comforts and fell asleep at the wheel for the past few decades...Join the Patreon here: https://www.patreon.com/PeterZeihanFull Newsletter: https://mailchi.mp/zeihan/the-swiss-are-screwed
Jeffrey Adolf Epstein. Isn't there a guy who owns the Smithsonian called Smith something? 1000 butts a day. I Didn't Order THCeeeeeeEEEEeeeeeeeeee! Inherently Voluptuous Rabbits. Riki Tiki Toddler. Do elephants have paws? Cause I'd like really wanted to know. Wasn't the head of the Manson Family called Charlie Something? Smoke Pizza Everyday. What's the Matterhorn? It's a bird, It's a plane! It's a squiggly line! Spy Women. Papa Ibbott Dunks on Everyone. Both Sides of the Aisle Are Covered in Cheetos Dust. None of your business with Wendi and more on this episode of The Morning Stream. Hosted on Acast. See acast.com/privacy for more information.
© 2020-2026 Ivy Podcast Discovery LLC
